Combination trastuzumab and chemotherapy may have a role in women with small, node-negative, human epidermal growth factor receptor 2-positive breast cancer

J Clin Oncol. 2015 Jan 1;33(1):124-5. doi: 10.1200/JCO.2014.58.2965. Epub 2014 Nov 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology*
  • Female
  • Humans
  • Neoplasm Recurrence, Local / chemistry*
  • Neoplasm Recurrence, Local / drug therapy*
  • Receptor, ErbB-2 / analysis*

Substances

  • Antibodies, Monoclonal, Humanized
  • Biomarkers, Tumor
  • Receptor, ErbB-2